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Summary During the haematogenous dissemination of this acute rat T-cell (Roser) leukaemia, infiltration of
both epididymal and testicular interstitial tissue has now been demonstrated, probably as an invariable
occurrence. The gonadal duct system itself was not invaded. In contrast to an earlier histopathological study
with this leukaemia, meningeal invasion has also been encountered during routine passage. Furthermore,
subsequent to remissions induced by carmustine (BCNU), relapse could occur as long as 80 days after the 20
day end point in control animals. This was associated with extensive infiltration of the meninges as well as in
the male gonadal interstitium, the proximal epididymis being particularly vulnerable. Two doses of carmustine
at intervals of one week could eradicate the disease even during the phase of logarithmic growth of the
leukaemic cells, this result depending upon the level of treatment and time of dosing post-inoculation with
leukaemic cells. Females carrying the disease were shown to be more readily cured than males, probably
related to entry of leukaemia cells into the gonadal interstitium.
This T-cell leukaemia appears to be an excellent model for the study and prospective chemotherapy of
testicular relapse in acute lymphoblastic leukaemia.
A recent attempt to utilize the L1210 mouse
lymphoblastic leukaemia as a model for the study
of testicular relapse in acute lymphoblastic
leukaemia was unsuccessful (Jackson et al., 1983,
1984). Primarily, this was due -to failure of the
malignant lymphoblasts to penetrate the gonadal
vasculature (testis or epididymis) via the
haematogenous route. However, using this system
with direct inoculation of leukaemic cells into the
peritubular tissue, circumstantial evidence was also
produced supporting the view that leukaemic cells
within the testicular interstitial tissue were relatively
protected from the destructive action of
cyclophosphamide (Jackson et al., 1983). The
present study demonstrates gonadal invasion
occurring during routine transmissions of an acute
rat T-cell lymphoblastic leukaemia and illustrates
its potential as a system for the investigation of the
cause and treatment of testicular relapse in the
human disease. The original detailed histo-
pathological report on this leukaemia (Dibley et al.,
1975) led to the conclusion that it showed close
resemblances to the human disease, but meningeal
infiltration, the cause of the meningeal syndrome in
man and apparantly, a common feature of human
T-cell leukaemia (Catovsky et al., 1974) was not
observed in this rat disease. No reference has
previously been made to the involvement of
reproductive system in this animal leukaemia.
Materials and methods
The leukaemia was kindly provided by Prof. W.L.
Ford, Department of Immunology in this Medical
School and maintained by serial passage in the
inbred hooded Oxford strain of rat (syngeneic with
PVG/c), in which it was originally induced. No
viral involvement has been demonstrated in this
leukaemia and growth is said to occur specifically
in this strain. Transmission of the disease by < 10
cells has been demonstrated (Dibley et al., 1975)
and our many transfers and experiments have
confirmed its 100% lethality. We have found the
i.m. injection of cells to be suitable for this study
and the following simple routine gives suspensions
providing a lethal end point of between 18 and 21
days.
Cervical lymph nodes (2-4 depending on size)
from animals approaching the terminal phase were
macerated with fine scissors in a Stendor dish.
Sterile saline (4ml) was added and the mixture
stirred. After sedimentation for about 2 min, 0.5 ml
was gently withdrawn from the surface layer using a
syringe barrel (1 ml) and added to 5.5 ml saline.
Transmission was readily accomplished by
intramuscular inoculation at this dilution (20,ul,
containing -20,000 cells) into the hind limb. In
some experiments, the intratesticular route was used
into the equatorial region of the gonad (10 or 2041).
More refined methods of preparing the cell
suspensions - filtration through gauze, centri-
fugation and washing were found to be unnecessary
in the context of the present work.
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In contrast to the mouse L1210 leukaemia
(Jackson et al., 1984), there was no evidence of local
tumour growth at the intramuscular site, whilst i.p.
inoculation did not lead to an ascitic type of
tumour.
Results and discussion
The gross findings in the terminal stages of the
disease in untreated rats were as reported
previously (Dibley et al., 1975) viz. splenomegaly
and enlarged cervical lymph nodes. In their
comprehensive study involving animals surviving up
to one month, the above authors found no evidence
of leukaemic infiltration of the meninges or cerebral
tissue. Among a relatively small number of control
animals in the present experiments, surviving about
3 weeks, one showed a distinct evidence of
meningeal involvement (Figure 1). When the
lifespan was increased by treatment with carmustine
(BCNU) intense infiltration of the meninges was
apparent with the development of relapse (Figures 2
and 3). In our earlier experiments using intravenous
inocula (about 2 x 105 cells), with lethality at about
14 days, it became evident histologically that
invasion of the male reproductive tract occurred.
These features were also apparent when the T-cells
were given i.m., with the end point of around 20
days. Testicular involvement usually appeared to be
restricted to small interstitial foci of malignant
lymphoblasts in the subcapsular region (Figure 4);
general extension into the interstitial tissue was an
occasional feature. Surprisingly, there was much
more substantial invasion of the epididymis,
predominantly in the caput region (Figures 5 and
6). It would appear that the epididymis is the
primary vulnerable site, but even with massive
invasion of the peritubular tissue in relapse after
chemotherapy the duct system was not penetrated
(Figure 6). When inoculated intratesticularly into
the lymphatic sinus spaces, leukaemic cells
proliferated around the seminiferous tubules. At 7
days, they could not be indentified with certainty
but by 14 days the infiltration was marked (Figure
7). The epididymis can also be involved in these
circumstances (Figure 8) suggesting direct spread
from testis to epididymis via the lymphatic system
although the haematogenous route cannot be
excluded. Subsequent to intratesticular inoculation,
systemic dissemination occurred rapidly (as we have
described for the L1210 mouse leukaemia) with a
fatal outcome at times comparable to that following
i.m. inoculation.
No studies on the susceptibility of this rat
leukaemia to chemotherapeutic agents have been
reported. Having determined the ability of these
malignant T-cells readily to establish themselves
within both testis and epididymis, the potential of
the model for the study of testicular relapse
necessitated knowledge of the ability of drugs to
produce suitable remissions. Attempts could then be
made to demonstrate that relapse could involve
residual cells in the testicular environment which
had survived chemotherapy. Comprehensive
chemotherapeutic studies on this leukaemia in an
inbred line of rats were not practicable in this
study. However, we have tested the response to a
number of conventional drugs - cis platinum,
adriamycin, cyclophosphamide, methotrexate,
prednisolone and carmustine (BCNU), the results of
which will be reported separately. Carmustine given
in two single doses at intervals of one week was by
far the most effective compound. Thus, when the
first dose (10mgkg-1 i.p.) was given between 7 and
10 days after i.m. inoculation with leukaemic cells a
proportion of rats appeared to be cured whilst
others achieved notable remissions (about 40-80
days). An occasional rat achieved no remission,
which is attributed to inadvertent injection of the
drug into the intestinal tract.
As the time of the first administration of the drug
was progressively delayed the number of "cures"
inevitably diminished until by day 13 post-
inoculation onwards for this level of treatment, the
mortality was 100%. Using BCNU on days 7 and
14 or days 10 and 17 after i.m. inoculation with T-
cells, the results (Table I) demonstrate quite clearly
that whereas all controls died about day 20, all
treated females survived, probably cured. Whereas
only 50% of males were apparently cured from the
former treatment, none survived from the latter
regimen although the remission in one animal
lasted 70 days, the cause of death undoubtedly
being leukaemia. The fact that males were
demonstrably more prone to relapse in the model
points to the testis as the protected environment. It
must be appreciated that the demonstration of such
differences are clearly governed by the experimental
circumstances - in particular the number and route
of inoculation of cells and the timing, route of
administration and level of drug dosage.
Our interpretation is that by day 7, when the
cells have been shown to enter the logarithmic
growth phase (Dibley et al., 1975), leukaemic cells
from the intramuscular site had, in some males,
penetrated into the interstitial tissue of the
epididymis and testis and were relatively protected
from the action of carmustine, for possible reasons
mentioned in our previous publication (Jackson et
al., 1983) on the mouse L1210 lymphoblastic
leukaemia. Thus the lower temperature of the testis
and the high functional activity of the epididymis of
the rat (Brooks, 1973) may be implicated in the
temperature-dependent reactivity of this unstable
alkylating chemical with cellular components.Figure 1 Meningeal infiltration by malignant rat T-lymphoblasts during routine transmission of the disease,
day 15 after i.m. inoculation. (x 100).
Figure 2 Extensive meningeal invasion accompanying relapse 42 days after i.m. innoculation with leukaemic
cells and two doses of carmustine (BCNU), l0mgkg- I i.p. on days 14 and 21. ( x 100).
619Figure 3 Lymphoblasts in the choroid plexus and meninges during relapse 42 days post-treatment with
BCNU as in Figure 2. (x 100).
Figure 4 Subcapsular infiltration of the rat testicular interstitium, 18 days after inoculation (IM) with
malignant T-cells. Leukaemic cells in the blood vessel have apparently penetrated into the surrounding
peritubular tissue. ( x 100).
620Figure 5 Extensive leukaemic involvement of the proximal epididymal interstitium in the same animal as in
Figure 4, illustrating the relative predilection of cells for this tissue compared with the testicular interstitium.
( x 100).
Figure 6 Caput epididymis (on L) and adjacent testis 42 days post-inoculation with leukaemic cells (IM).
Treatment BCNU (10mgkg-1) on days 14 and 21. This emphasizes again the relative preference of the
leukaemic cells for the epididymal site. ( x 100). A?
%MEMENIMOM.1IL- --4mwm.
1LFigure 7 Peritubular spread by 14 days of leukaemic lymphoblasts following intratesticular inoculation into
the lymphatic sinus network of the testis. No penetration into the seminiferous tubules. ( x 100)
Figure 8 Intratesticular innoculation of leukaemic cells. At 15 days leukaemic cells have reached the
epididymis probably by lymphatic communications from the testis but the systemic haematogenous route is
possible. Vascular channels (bottom R) contain tumour cells. ( x 100).
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Table I Rat T-cell leukaemia model. Sex difference in cure rate with chemotherapy (carmustine, BCNU) due to T-cell
"sanctuary" in testis
I Adult rats inoculated with -20,000 cells (i.m.). Treatment - 1 dose carmustine (10mgkg-1 i.p.) on each of days 7
and 14.
8 rats per group
Mortality
Controls (males+females) 8/8 (3 weeks)
Treated females 0/8 (> 3 months)
Treated males 4/8 (no deaths beyond 2 months)
II As in I but treatment deferred until days 10 and 17.
(Cell inoculation i:m.) Mortality
Control females 4/4
Treated females 0/4 (by 2 months)
Treated males 3/4 (by 2 months, 4th at 70 days)
(Cell inoculation intratesticular) 4/4 (by 2 months)
Treated males
Explanation: The chemotherapy (without obvious side effects) eliminates all leukaemic cells (including any in the
meninges) but not those which have localized or been injected into the testis. Hence, 100% "cure" in females but not in
males.
It is remarkable that these malignant T-cell
lymphoblasts show a predilection to invasion of the
caput epididymis. This variant of the human
disease has been considered to be more aggressive
(Catovsky et al., 1974). Regional functions within
the epididymis are complex (Waites & Setchell,
1969; Hamilton, 1972), the great majority of
testicular fluid entering from the ductuli efferentes
being absorbed in the caput epididymis. Androgen
binding protein (ABP) secreted by Sertoli cells in
the testis, together with its testosterone is also
highly concentrated in this region (Purvis &
Hansson, 1978). Whether such intense physiological
activity correlates in some way with a normal T-cell
lymphocytic function in this region is speculative.
The contrast with the inability of mouse malignant
lymphoblasts (L1210) to penetrate the epididymal
interstitium and tubule is apparent (Jackson et al.,
1984).
By careful definition of the experimental
conditions and the use of the short-lived BCNU it
may be practicable to use this rat model system to
test the prospective efficiency of drugs against
residual leukaemic cells within the male gonadal
environment, thus simulating the circumstances of
testicular relapse. On the other hand, female rats
bearing this leukaemia with their lifespan
appropriately extended by the same BCNU
treatment also present the opportunity to assess
drug effectiveness against meningeal leukaemia.
Prolongation of the lifespan of L1210 leukaemic
mice using methotrexate was shown many years
ago to result in meningeal leukaemia (Thomas et
al., 1964). The important features in this rat model
are that malignant lymphoblasts reach their
destination by the haematogenous route, whilst the
time scale of the disease is extended compared with
the mouse model, which promises a more realistic
approach to treatment regimens. Finally the onset
of the terminal phase is readily discernible in this T-
cell leukaemia by cervical lymph node enlargement
and general malaise in contrast to the frequently
rapid end-point in the L1210 mouse, even within a
few hours. Thus, in the rat, measures can always be
taken to obtain histopathological evidence as to the
circumstances of the impending death.
This research was supported by the Leukaemia Research
Fund.
References
BROOKS, D.E. (1973). Epididymal and testicular
temperature in the unrestrained conscious rat. J.
Reprod. Fert., 35, 157.
CATOVSKY, D., GOLDMAN, J.M., OKOS, A., FRISCH, B. &
GALTON, D.A.G. (1974). T-lymphoblastic leukaemia: A
distinct variant of acute leukaemia. Br. Med. J., fi,
643.
DIBLEY, M., DORSCH, S. & ROSER, B. (1975). T-cell
leukaemia in the rat: The pathophysiology. Pathology,
7, 219.
HAMILTON, D.W. (1972). The epididymis as a possible site
for fertility control in the male. Adv. Biosciences, 10,
127.624 H. JACKSON et al.
JACKSON, H., BOCK, M., JACKSON, N.C. & LENDON, M.
(1983). The testis: A protected environment for
leukaemic cells against cyclophosphamide in a mouse
model. Cancer Chemother. Pharmacol., 11, 200.
JACKSON, H., JACKSON, N.C., BOCK, M. & LENDON, M.
(1984). Testicular relapse in acute lymphoblastic
leukaemia: Studies with an experimental mouse model.
Br. J. Cancer, 49, 73.
PURVIS, K. & HANSSON, V. (1978). Androgens and
androgen-binding protein in the rat epididymis. J.
Reprod. Fert., 52, 59.
THOMAS, L.B., CHIRIGOS, M.A., HUMPHREYS, S.R. &
GOLDIN, A. (1964). Development of meningeal
leukaemia (L1210) during treatment of
subcutaneously-inoculated mice with methotrexate.
Cancer, 17, 352.
WAITES, G.M.H. & SETCHELL, B.P. (1969). Physiology of
the testis, epididymis and scrotum. Adv. Reproductive
Physiol., 4, 1.